Back to results
US 9,284,350 B2Granted
IAP BIR domain binding compounds
AssigneePharmascience Inc.
InventorsAlain Laurent, Melanie Proulx, Yannick Rose, Irina Denissova, Kenza Dairi, Scott Jarvis, James B. Jaquith
Life of this patent
Estimating the term…
Abstract
A compound of Formula 1: (I) or salt thereof, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods.
Claims39
A compound of Formula 1:
- or a salt thereof, wherein
- R1 is H or alkyl;
- R2 is methyl or ethyl;
- R3 is alkyl, cycloalkyl, heterocyclyl, heteroaryl, or aryl, any of which can be optionally further substituted with an amino, alkylamino, or alkoxy;
- R4 and R5 are each, independently, H or alkyl;
- R6 is H, halogen, or alkoxy;
- X is O, S, CH2, —(CH2)2— or CH—R7, wherein R7 is NR8, OR8, NC(O)OR8, NHC(O)R8 or NHSO2R8, wherein R8 is alkyl, cycloalkyl, heterocyclyl, aryl, arylalkyl, or heteroaryl, any of which can be optionally further substituted with an alkyl, alkoxy, haloalkyl, or halogen;
- or X is
- and G is
- wherein R9 is substituted or unsubstituted alkyl, cycloalkyl, heterocyclyl, aryl or heteroaryl;
- or
- (2) a substituted or unsubstituted azole or pyrrole ring, optionally fused to a substituted or unsubstituted aryl, heteroaryl, cycloalkyl or heterocyclyl.
9 more elements
Dependencies are inferred from the claim text.